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FRETn factor regulating the antioxidant response. When exposed to oxidative stress,
Nrf2 translocates to cell nucleus and forms heterodimer with small Maf proteins (sMaf). Nrf2/sMaf
heterodimer binds speciﬁcally to a cis-acting enhancer called antioxidant response element and initiates
transcription of a battery of antioxidant and detoxiﬁcation genes. Nrf2 possesses a NESzip motif (nuclear
export signal co-localized with the leucine zipper (ZIP) domain). Heterodimerization with MafG via ZIP–ZIP
binding enhanced Nrf2 nuclear retention, which could be abrogated by the deletion of the ZIP domain or site-
directed mutations targeting at the ZIP domain. In addition, dimerization with MafG precluded Nrf2zip/
CRM1 binding, suggesting that Nrf2/MafG heterodimerization may simultaneously mask the NESzip motif.
MafG-mediated nuclear retention may enable Nrf2 proteins to evade cytosolic proteasomal degradation and
consequently stabilize Nrf2 signaling. For the ﬁrst time, we show that under the physiological condition, the
NESzip motif can be switched-off by heterodimerization.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionTo adapt to their aerobic life style, mammalian cells have developed
elaborate yet highly efﬁcient cytoprotectivemachinery.When exposed
to oxidative stress, these cells can respond with a rapid and
coordinated expression of a battery of gene products, including
phase II detoxiﬁcation enzymes/antioxidants and phase III efﬂux
transporters [1–3]. As a consequence, these cells can effectively
neutralize and remove excess oxidants to quickly restore redox
homeostasis. The antioxidant response is exquisitely regulated. Four
components, namely, Nrf2 (NF-E2 related factor 2) [4], Keap1 (Kelch-
like ECH-associated protein 1) [5], a group of small musculoapo-
neurotic fibrosarcoma (Maf) proteins [6] and a cis-acting enhancer
called antioxidant response element (ARE) or electrophile responsive
element (EpRE) [7–9], are found essential for the regulation of the
antioxidant response [10].
Pivotal to the antioxidant response is Nrf2 [4]. Nrf2 is a basic leucine
zipper (bZIP) transcription factor featuring a Cap “N” Collar (CNC)
structure [4]. Like many other transcription factors, Nrf2 signaling is
regulated by compartmental segregation. Under unstressed condition,
Nrf2 is found mainly sequestered in the cytoplasm by its cytosolic
repressor Keap1 [1]. Keap1 is also a Cullin 3-dependent substrate
adaptor protein for ubiquitin ligase E3 complex [11–14]. So Nrf2
molecules may not only be sequestered by Keap1 but also subjected toax: +1 732 445 3134.
).
l rights reserved.constant degradation in the cytoplasm. When challenged by oxidative
stress derived fromaccumulation of reactive oxygen species (ROS) [15–
17] or reactivenitrogen species (RNS) [18,19], theKeap1-mediatedNrf2
ubiquitination and degradation is impeded in a redox-sensitive
manner [20]. In contrast, Nrf2 protein translation is enhanced [21].
The relative abundance of Nrf2 proteins may surpass the Keap1
sequestering capacity. As a consequence, the pool of unbound Nrf2
proteins expands. Since unbound Nrf2 exhibits a graded nuclear
translocation correlated with the intensity of oxidation [22], certain
amount of Nrf2 proteins translocate into the nucleus and form
heterodimer with small Maf proteins. Small Maf (sMaf) proteins,
composed of MafF, G and K, are a group of bZIP bi-directional
transcription regulators [6,23]. The sMaf proteins per se lack the
transactivation domain, so the sMaf/sMaf homodimers function as
transcription repressors [24]. Whereas Nrf2 cannot form homodimer
[25,26], the Nrf2/sMaf heterodimer exhibits high recognition speciﬁ-
city and binding afﬁnity to ARE/EpRE [25] located in the promoter of
diverse phase II/III cytoprotective genes [6,27]. The binding of Nrf2/
sMaf heterodimer to ARE/EpRE thus triggers the transcription of these
cytoprotective genes.
Recently, the mechanisms governing the subcellular localization of
unbound Nrf2 have been elucidated. One bipartite nuclear localization
signal (NLS) is identiﬁed in the basic region of Nrf2 [28,29], called
bNLS. One nuclear export signal (NES) is characterized in the ZIP
domain of Nrf2 [28,29], called NESzip. In addition, another NES motif
is characterized in the transactivation (TA) domain of Nrf2 [22,30],
called NESTA. The existence of multiple NLS/NES motifs in Nrf2 implies
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activities of these motifs. The driving force of individual NLS/NES
motif has been analyzed [22]. The combined nuclear exporting
activities exerted by both the NESzip and NESTA motifs appear to be
able to counteract the nuclear importing activity mediated by the
bNLS motif [22]. Disabling of either the NESzip or the NESTA motif by
mutations results in Nrf2 nuclear localization [22]. These results
naturally raise the question of whether these NLS/NES motifs can be
turned on/off under normal physiological conditions and conse-
quently alter the subcellular localization of Nrf2.
Previous studies found that under oxidized condition, the NESTA
motif could be disabled, probably by sulfhydryl modiﬁcation at
cysteine 183 (C183) residue embedded in the NESTA motif [22]. The
sulfhydryl modiﬁcation on C183 residue may generate steric hin-
drance for the binding of nuclear exporting protein chromosome
region maintenance 1 (CRM1) [22]. So the NESTA motif appears to be a
conditional NES motif that can be turned off by oxidants.
The position of the NESzipmotif is overlappedwith the ZIP domain
[28]. In the present study, we ﬁnd that heterodimerization with sMaf
proteins can simultaneously mask the NESzip motif and preclude
NESzip/CRM1 binding. For the ﬁrst time we show that the NESzip
motif can also be turned off under the physiological condition.
2. Materials and methods
2.1. Cell culture, chemicals and antibodies
Human cervical squamous cancerous HeLa cells and human
embryonic kidney (HEK) cells were obtained from ATCC (Manassas,
VA). HeLa and HEK cells were cultured as monolayer using minimum
essential medium (MEM) supplemented with 10% fetal bovine serum,
2.2 mg/ml sodium bicarbonate, 100 U/ml penicillin and 100 μg/ml strep-
tomycin. Rabbit anti-MafG/K (H-100), anti-Nrf2 (H-300), anti-CRM1
(H-300), anti-Lamin A (H-102), anti-GAPDH (FL-335), anti-HO-1 (H-105)
andanti-NQO1 (H-90),mouseanti-GST (B-14) probeswere all purchased
from St. Cruz Biotech (St. Cruz, CA). Mouse anti-Myc (9B11) probe was
purchased from Cell Signaling (Danvers, MA).
2.2. Plasmid construction, site-directed mutagenesis and RT-PCR
The construction of the EGFP-Nrf2zip [28] and pHM6-Nrf2 [31]
plasmids have been described before. Human MafG cDNA [32] was
PCR ampliﬁed and subcloned into pDsRed-Monomer vector (ClonTech,
Mountain View, CA). The deletion mutants of MafG, MafGzip (72–162
a.a.) and MafGΔzip (1–71 a.a.), were generated by PCR ampliﬁcation
and inserted into pDsRed-Monomer (mDsRed) vector. For FRET
studies, Nrf2zip and MafG were PCR ampliﬁed and subcloned into
pECFP-C1 and pEYFP-C1 vector (ClonTech), respectively. Alanine
substitute mutations were performed using QuikChange XL site-
directed mutagenesis kit (Stratagene,La Jolla, CA) according to the
manufacturer's instruction. Brieﬂy, both sense and antisense muta-
genic oligonucleotide primers were designed to mutate leucine to
alanine. The primers were synthesized and PAGE/HPLC-puriﬁed by
Integrated DNA Technologies, Inc (Coralville, IA). Mutagenesis reac-
tions were performed in 50 μl reaction solution containing 100 ng
template DNA, 125 ng sense and antisense mutagenic primers, 1X
reaction buffer with dNTP supplement, 3 μl QuikSolution, 2.5 U Pfu
Turbo DNA polymerase and double distilled water. Mutagenesis
reaction was performed at the condition of denaturing at 95 °C for
1 min, followed by 18 cycles of thermal cycling reaction (95 °C for 50 s,
60 °C for 50 s and 68 °C for 7min) and concluded by 7min extension at
68 °C. The parental methylated dsDNA plasmids were subsequently
digested by Dpn I at 37 °C for 3 h. Afterwards, the thermal cycling
products were transformed into ultra-competent XL10-Gold cells
(Strategene). Themutant plasmidswere extracted and veriﬁed byDNA
sequencing. We also constructed a pcDNA3.1-Myc-MafG to add a Myctag (EQKLISEEDL) [33] to the N-terminus of MafG.We also constructed
a pcDNA3.1-Nrf2-V5 to add a V5 tag (GKPIPNPLLGLDST) [34] to the
C-terminus of Nrf2. To analyze the transcription of phase II genes,
3 μg pcDNA3.1-Nrf2-V5 plasmid was expressed alone or co-expressed
with 1 μg pcDNA3.1-Myc-MafG or pcDNA3.1-Myc-MafG2p mutant in
HeLa or HEK cells. RNA was extracted using RNeasy mini kit (Qiagen,
Valencia, CA) according to manufacturer's instruction and reverse
transcribed (RT) using Superscript First-Strand Synthesis System III kit
(Life Technologies, Rockville, MD). The RT products were further
analyzed by PCR reaction. The PCR primers for HO-1, NQO1 [35] and
UGT1A1 [36] have been described before. The PCR reaction was
denaturing at 95 °C for 5 min, followed by 40 cycles of thermal cycling
reaction (95 °C for 1 min., 55 °C for 30 s and 68 °C for 1 min) and
concluded by 10 min extension at 72 °C. The RT-PCR products were
resolved in 1% agarose gel supplemented with ethidium bromide and
visualized in UV light.
2.3. GST pull-down, competitive binding assay and Western blotting
The expression and puriﬁcation of (His)6-CRM1 proteins has been
described before [28]. (His)6-MafG protein was prepared using the
similar protocol. Brieﬂy, human MafG was PCR ampliﬁed and
subcloned into the pQE30 vector (Qiagen). The pQE30-MafG plasmid
was transformed into Escherichia coli M15 cells (Qiagen). Expression
of (His)6-MafG proteins was induced by 0.5 mM of isopropyl β-D-
thiogalactoside (IPTG) for 4 h at 30 °C and puriﬁed by Ni-NTA slurry
(Qiagen). To put a GST tag on Nrf2zip, Nrf2zip was PCR ampliﬁed and
subcloned into the pGEX-2T vector (GE Healthcare, Piscataway, NJ).
The pGEX-Nrf2zip plasmid was transformed into DH5α Escherichia
coli and induced by 0.8 mM IPTG at 30 °C overnight. GST-Nrf2zip
proteins were puriﬁed by glutathione (GSH) conjugated beads
(Novagen) and eluted with 10 mM GSH in 50 mM Tris buffer.
Subsequently, GSH was eliminated in a solution exchange experiment
using MicroCon YM-30 spin column (Millipore, Billerica, MA). GST-
Nrf2zip protein was preserved in incubation buffer (phosphate-
buffered saline (PBS), 0.1% TX-100, pH7.3) supplemented with 1 mM
dithiothreitol (DTT) to avoid auto-oxidation. In MafG/CRM1 compe-
titive binding experiment, 1 μg GST-Nrf2zip proteins were ﬁrst mixed
with GSH-conjugated beads in incubation buffer supplemented with
fresh 1 mM 2-mercaptoethanol (ME) and tumbled at 4 °C for 30 min.,
subsequently, 2 μg (His)6-CRM1 together with 0, 1, 5 μg (His)6-MafG
were added into GST-Nrf2zip solution and tumbled at 4 °C for 2 h. The
pellets were extensively washed and dissolved in 50 μl gel loading
buffer supplementedwith 2-ME. The samples were heated at 95 °C for
5 min and subjected to Western blotting examination. For western
blotting—cell lysates containing 20 μg proteins were resolved by 4–
15% linear gradient SDS-polyacrylamide gel (BioRAD, Hercules, CA)
electrophoresis and transferred to polyvinylidene diﬂuoride mem-
brane using a semi-dry transfer system (Fisher). The membrane was
blocked with 5% nonfat milk in Tris-buffered saline with Tween-20
(TBST) containing 20 mM Tris–HCl, 8 mg/ml NaCl, and 0.2% Tween-20
(pH 7.6) at room temperature for 1 h. The membrane was probed with
polyclonal rabbit anti-Nrf2 (1:500), anti-CRM1 (1:500), anti-MafG/K
(1:500), anti-GAPDH (1: 10,000), anti-Lamin A (1:500), anti-HO-1
(1:500), anti-NQO1 (1:500) and monoclonal anti-GST (1:10,000) and
anti-Myc (1:500) in 3% nonfat milk TBST at 4 °C overnight. After
washing three times with TBST, the membrane was blotted with
peroxidase-conjugated secondary antibody (1:5000 dilution) at room
temperature for 1 h. Proteins were visualized using the ECL mixture
from BioRAD.
2.4. Transient transfection and reporter gene activity assays
Transactivation activity assay has been described in detail before
[37]. Brieﬂy, HeLa cells were plated in six-well plates at ∼4.0×105
cells/well. Twenty four hours after plating, cells were transfected
1849W. Li et al. / Biochimica et Biophysica Acta 1783 (2008) 1847–1856using the Lipofectamine method according to manufacturer's instruc-
tions. For each well, 500 ng pARE-TI-Luc reporter containing a single
copy of murine GST Ya ARE, 1 μg pHM6-Nrf2 were co-expressed with
0,1,10, 25 and 100 ng plasmids expressing wild type or 2 point mutant
MafG. Lipofectamine 2000 (Life Technologies) was added into another
tube of 125 μl OPTI-MEM in a 1:2.5 ratio to the amount of plasmids and
incubated at room temperature for 5 min. The plasmid solution was
then mixed with lipofectamine solution with vigorous agitation and
incubated at room temperature for 30 min. Cells were incubated with
transfection complexes for 3 h, changed to fresh MEM medium and
cultured for 16 h. Cells were washed twice with PBS, scraped, and
incubated in reporter lysis buffer (Promega, Madison, WI) on ice for
30 min. After centrifugation, 10 μl lysate was mixed with luciferase
substrate (Promega) and the ARE-luciferase activity was measured
using a Sirius luminometer (Berthold Detection System). Protein
concentration was measured using the Bradford method. Luciferase
activity was normalized by protein concentration.
2.5. Cell fractionation
The protocol to extract nuclear and cytoplasmic proteins has been
described before [38] with minor modiﬁcation. Brieﬂy, HeLa cells were
cultured in 60 mm Petri dishes and transfected with 3 μg pcDNA3.1-
Nrf2-V5 alone or with 1 μg pcDNA3.1-Myc-MafG or MafG2p mutantFig. 1.Molecular structure of Nrf2 and MafG. (A) Schematic illustration of Nrf2 molecule and
(Neh) domains. The Neh1 contains the ZIP domain (LLLNLL), the basic region (++) and th
permissive role of Nrf2 transactivation. The tandem of Neh4 and Neh5 domains mediates co
region. Nrf2 possesses a bipartite NLS (double bars) in the basic region and two NES motifs
according to their position in heptad structure (bottom panel). The demarcation leucines ar
Schematic illustration of MafG molecule and plasmid constructs. Typical for small Maf molec
domain, a basic domain (++) and a ZIP domain (LLLMLL). (C) Side view and (D) end view of
monomer bind with “d′” and “a′” residue of its partner monomer, respectively.using the Lipofectamine method (Life Technologies). After 24 h, cells
were rinsed with ice-cold PBS and harvested with cell lysis buffer A
(50 mM Tris–HCl, 10 mM NaCl, 5 mM MgCl2, 0.5% NP-40, pH8.0). After
incubation on ice for 10 min, the samples were centrifuged at 12,000 g
for 15 min. Supernatants (cytosolic extract) were collected. Nuclear
pellets were washed twice with cell lysis buffer A, and then re-
suspended in high salt buffer B (20mMHEPES, 0.5 M NaCl, 1 mM EDTA,
1 mM DTT, pH7.9), vortexed, and centrifuged. Supernatants (nuclear
extract) were collected. The protein concentration of each sample was
measured. To generate homogenous electrophoretic pattern, cytosolic
proteins were diluted in buffer B. 20 μg nuclear proteins and 10 μg
cytosolic proteins were loaded for immunoblot analysis.
2.6. Epiﬂuorescent microscopy
The expression and subcellular distribution of EGFP-Nrf2zip at the
presence of mDsRed-MafG and its mutants were examined using a
Nikon Eclipse E600 epiﬂuorescentmicroscope and a Nikon C-SHG1UV
light source purchased from Micron-Optics (Cedar Knolls, NJ). HeLa
and HEK cells were cultured on ethanol-sterilized glass coverslips and
transfected with 1 μg of EGFP-Nrf2zip together with 0.2 μg mDsRed
tagged MafG, MafGzip or MafGΔzip using the Lipofectamine method
(Life Technologies) and further cultured in MEM for 24 h. The EGFP
signals were examined using a FITC ﬁlter. The mDsRed signals wereplasmid construct. Nrf2 has some highly conserved domains called Nrf2-ECH homology
e CNC domain. The Neh2 domain mediates Keap1 binding. The Neh3 domain plays a
operative transactivation activity of Nrf2. The Neh6 domain locates in the intervening
(black circles). The comprising residues of the ZIP domain of Nrf2 (top panel) are listed
e underlined. The composing leucine residues of the NESzip motif are in bold fonts. (B)
ules, MafG lacks transactivation domain. MafG has an extensive homology region (EHR)
coiled coil helix of the ZIP motif. When forming dimer, the “a” and “d” residues of one
Fig. 2. MafG enhances Nrf2 nuclear retention via ZIP–ZIP dimerization in Hela cells.
Epiﬂuorescent microscopic examination showed that mDsRed-MafG could arrest EGFP-
Nrf2 (A–C) and EGFP-Nrf2zip (D–F) in cell nucleus. In contrast, mDsRed-MafG2p failed
to arrest EGFP-Nrf2zip in the nucleus (G–I). The mDsRed-MafGzip showed co-
localization with EGFP-Nrf2zip (J-L). In the absence of mDsRed-MafGzip, EGFP-Nrf2zip
maintained a cytosolic distribution (arrow, J, L). In contrast, mDsRed-MafGΔzip failed to
change EGFP-Nrf2zip distribution (M–O). The left, middle and right column shows EGFP,
mDsRed and superimposed images, respectively. Scale bar: 10 μm.
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digitized using a Nikon DXM1200 camera and a Nikon ACT-1 software
(version 2). Images were superimposed by Adobe Photoshop CS
software.
2.7. Confocal microscopy and Fluorescence Resonance Energy Transfer
(FRET) assay
For FRET assay, HeLa cells were transfected with plasmids
expressing ECFP-Nrf2zip (2 μg), and EYFP-MafG or EYFP-MafG
mutants (1 μg) in glass bottom dishes (MatTek, Ashland, MA).
Twenty four hours after transfection, cells were examined using a
Zeiss LSM510 laser scanning confocal microscope (Zeiss, Thornwood,
NY) with a 63X water-immersion objective. We used a sensitized
emission method for the FRET assay [39,40]. Three ﬁlter sets were
used to detect the donor (ECFP), acceptor (EYFP) and FRET signals.
The FRET signal is corrected for spectral bleed through and
contamination of donor and acceptor ﬂuorescence according to
Youvan's formula (1) [40]:
Fc ¼ FRET−bgfretð Þ−cfdonS Don−bgdonð Þ−cfaccS ACC−bgaccð Þ ð1Þ
(Abbreviation: Fc = FRETconcentration, bg = background intensity, cf =
correction factor, fret = FRET signal, don = Donor signal, acc = Acceptor
signal).
The FRET concentration was normalized to donor and acceptor
concentrations according to the following formula (2):
Fn ¼ Fc=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Don−bgdonð ÞS Acc−bgaccð Þ
q
ð2Þ
For data acquisition, the donor (ECFP) channel was excited with an
Argon laser line at 457 nm and the emissionwas detected using a band
pass ﬁlter of 475–525 nm. The acceptor (EYFP) channel was excited at
543 nm and its emission was detected at 545–600 nm. The FRET
channel was excited at 457 nm and the emissionwas detected at 545–
600 nm. For data analysis, we used the LSM510 SP2 software (version
3.2) to subtract donor and acceptor bleed through and normalize
against acceptor (EYFP) and donor (ECFP) intensity.
3. Results
3.1. The NESzip motif co-localizes with the ZIP dimerization domain
One salient feature of the molecular structure of Nrf2 is the
overlapping positioning of functional motifs. The bNLS motif is co-
localized with the basic DNA binding domain (Fig. 1A). The NESTA
motif is co-localized with the Neh5 transactivation domain (Fig. 1A).
The NESzip motif is co-localized with the ZIP dimerization domain
[28] (Fig. 1A). Consensus ZIP dimerization domain forms a parallel
coiled coil [41] that consists of 4–6 heptads interspersed regularly by
leucine residues. Therefore the ZIP domain are also called leucine
zipper and formulated as L1L2L3L4L5L6. For Nrf2, the key position of
the fourth heptad is a polar asparagine (N) residue, which may
preclude the formation of Nrf2/Nrf2 homodimer [25,26]. So the ZIP
domain of Nrf2 can also be formulated as L1L2L3N4L5L6 (Fig. 1A). For
MafG, the key position of the fourth heptad is a hydrophobic residue
methionine, so the ZIP domain of MafG can be represented as
L1L2L3M4L5L6 (Fig. 1B).
The ZIP domain can also be formulated as (abcdefg)4–6, with each
composing residue in every heptad is represented by letter “a” to “g”,
respectively. To achieve ZIP–ZIP dimerization, the position “a” and “d”
need to be hydrophobic residues. In the process of dimerization, the
“a” and “d” residue in one monomer interact with the complementary
“d′” and “a′” residue in the opposite monomer, respectively [26] (Fig.
1C–D). The interaction forms a hydrophobic core essential for dimer
stability [42].Canonical NES motif can be formulated as Φ1–(X–X)2–3–Φ2–(X–
X)2–3–Φ3–X–Φ4.Φ represents hydrophobic amino acids residues such
as leucine, isoleucine, valine, methionine and phenylalanine, and X
can be any amino acids [43–45]. In the NESzip motif of Nrf2 (in the
589 a.a. frame), theΦ1 (L537) andΦ3 (L544) residues are located at the
“d” position in the ﬁfth and sixth heptad of ZIP domain, respectively.
TheΦ2 (L541) residue is located at the “a” position in the sixth heptad
(Fig. 1A). In other words, this NESzip motif occupies three key
positions in the dimerization domain. The overlap between the NESzip
and the ZIP motif implies that when Nrf2 forms heterodimer via
leucine zipper with its obligatory binding partner small Maf proteins,
the NESzip motif may be simultaneously masked.
3.2. Dimerization with MafG enhance nuclear retention of Nrf2
To examine this possibility, we co-expressed an enhanced green
ﬂuorescent protein tagged Nrf2 (EGFP-Nrf2) with a monomer Disco-
soma sp. red ﬂuorescent protein tagged MafG (mDsRed-MafG) in HeLa
cells. When expressed alone, EGFP-Nrf2 exhibited a mainly whole cell
distribution [22] and mDsRed-MafG exhibited a nuclear distribution
(data not shown). When EGFP-Nrf2 was co-expressed with mDsRed-
MafG, we observed that mDsRed-MafG could concentrate EGFP-Nrf2
proteins in the nucleus (Fig. 2A–C). This nuclear retention effect
appeared to be speciﬁc for sMaf proteins, since MafK could also cause
accumulation of Nrf2 in cell nucleus (data not shown). In contrast,
mDsRed per se failed to alter Nrf2 subcellular distribution (data not
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MafK was able to accumulate CNC-bZIP transcription repressor Bach 2
in the nucleus [46].
To verify that Nrf2/MafG interaction is mediated by the ZIP
domain, we co-expressed EGFP tagged Nrf2zip, a Nrf2 segment that
only contains the ZIP domain of Nrf2 (Fig. 1A), with mDsRed-MafG.
Whereas EGFP-Nrf2zip mainly exhibited a cytosolic distribution
when expressed alone [28], mDsRed-MafG converted it into a nuclear
distribution pattern (Fig. 2D–F), suggesting that the Nrf2/MafG
interaction is mediated by the ZIP domain. In contrast, when EGFP
tagged Nrf2Δzip, a Nrf2 segment with the ZIP domain truncated, was
co-expressed with mDsRed-MafG, mDsRed-MafG failed to change the
distribution of EGFP-Nrf2Δzip (data not shown). In addition, when
the L108 and L115 residues of the ZIP domain of MafG were mutated
to alanines, the co-expression of this double point mutant of MafG
(MafG2p) failed to alter the cytosolic distribution pattern of Nrf2zip
(Fig. 2G–I). We also generated MafG deletion mutants. We truncated
the amino-terminus of MafG, including the extensive homology
region (EHR) and the basic DNA binding domain, but kept the ZIP
domain of MafG intact. The resultant mutant was called MafGzip (Fig.
1B). When mDsRed-MafGzip was expressed alone, it showed a whole
cell distribution pattern (data not shown), probably due to the
deletion of the NLS motif located in the basic DNA binding region of
MafG. When mDsRed-MafGzip was co-expressed with EGFP-Nrf2zip,
mDsRed-MafGzip converted the EGFP-Nrf2zip into a whole cellFig. 3. Dimerizationwith MafG enhances nuclear retention of Nrf2. (A) GST pull down study s
mutation in Nrf2zip attenuated MafG binding. Two point (2p) mutation further decreased Ma
FRET value showed strong interaction between Nrf2zip/MafG. FRET value was attenuated in
YFP failed to elicit FRET signal. (C–N) Confocal microscopy and FRET assay of MafG/Nrf2zip b
nucleus. In the absence of EYFP-MafG, ECFP-Nrf2zip exhibited a cytosolic distribution (arr
overlapped with the nuclear location of EYFP-MafG2p. To enhance visual effect, the EYFP
respectively. Scale bar: 10 μm.distribution (Fig. 2J–L). In contrast, in the absence of mDsRed-
MafGzip, EGFP-Nrf2zip exhibited a cytosolic distribution (arrow, Fig.
2J, L). The co-localization of MafGzip with Nrf2zip suggested that
MafGzip/Nrf2zip binding was very likely mediated by the ZIP
domain. We also generated MafG truncation mutant that lacks the
ZIP domain (MafGΔzip) (Fig. 1B). In the absence of ZIP domain of
MafG, EGFP-Nrf2zip exhibited a cytosolic distribution even at high
concentration of mDsRed-MafGΔzip (Fig. 2M–O). In combine, these
data suggested that it is the ZIP domain that mediates Nrf2/MafG
heterodimerization. Similar results were also observed in HEK cells
(Supplementary Fig. 1).
3.3. Site mutations disrupting dimerization negated MafG-mediated
nuclear retention of Nrf2
To collect more speciﬁc evidence that MafG-mediated Nrf2 nuclear
retention is mediated by the ZIP–ZIP interaction, we selectively
ablated the key leucine residues located in the ZIP domain. In a GST
tagged Nrf2zip fusion protein (GST-Nrf2zip), we generated single
point (1p) mutant (L537A or L544A), double point (2p) mutant
(L537AL544A) and four point (4p) mutant (L537AL541AL544AL546A).
In addition, in MafG protein, we also made single point mutant (L108A
or L115A) and double point mutant (L108AL115A). The MafG (L108A),
MafG (L115A) and MafG2p mutant can also be designated as L5A, L6A,
and L5AL6A mutant, respectively.howed that wild type Nrf2zip exhibited the strongest binding to MafG. Single point (1p)
fG binding. Four point (4p) mutation completely abolished MafG binding. (B) Calculated
Nrf2zip/MafG1p and completely negated in Nrf2zip/MafG2p. As a negative control, CFP/
inding. ECFP-Nrf2zip showed co-localization with EYFP-MafG and EYFP-MafG1p in the
owheads) (D–E). ECFP-Nrf2zip however, showed a discrete cytosolic distribution, un-
, ECFP and FRET signals are artiﬁcially represented with red, green and white color,
Fig. 4. Dimerization with MafG precludes Nrf2zip/CRM1 binding. 1 μg of GST-Nrf2zip
proteins and 2 μg (His)6-CRM1 proteins were incubatedwith different amount of (His)6-
MafG proteins (0, 1 and 5 μg). GST pull-down results showed that MafG inhibited
Nrf2zip/CRM1 binding in a dose-dependent manner.
Fig. 5. MafG regulates Nrf2 signaling. (A) Reporter gene activity assay. Co-expressing
wild type MafG regulated Nrf2 induced ARE-luciferase activities in a bi-directional way.
In contrast, co-expressing MafG2p mutant markedly inhibited Nrf2 induced ARE-
luciferase activities in a dose dependent way. Hela cells were transfected with 1 μg
pHM6-Nrf2, 0.5 μg plasmid expressing ARE-Luc together with 0, 1, 10, 25 and 100 ng
plasmids expressing wild type (wt) or 2p mutant (mt) MafG. Twenty four hours after
transfection, cells were harvested. Luciferase activity was measured and normalized to
protein concentration. Single and double asterisks indicate statistical signiﬁcance (t-
test) of pb0.05 and pb0.01, respectively. (B) RT-PCR analysis of the transcription of
phase II genes. 3 μg pcDNA3.1-Nrf2-V5 plasmids were expressed alone or co-expressed
with 1 μg pcDNA3.1-Myc-MafG or pcDNA3.1-Myc-MafG2p in HeLa cells. Total RNAs
were extracted using RNeasymethod and reversed transcribed (RT). Same amount of RT
samples were ampliﬁed by poly chain reaction (PCR) for 40 cycles and resolved in 1%
agarose gel and visualized by ethidium bromide incorporation exited by UV light. The
densitometric values of RT-PCR products were labeled underneath. (C)Western blotting
results showed thatMafG andMafG2p could enhance and attenuate Nrf2-induced HO-1
and NQO1 expression, respectively.
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point mutation in the ZIP domain of Nrf2zip attenuated Nrf2zip1p/
MafG binding (Fig. 3A). In comparison, the double point mutations
could severely reduceNrf2zip2p/MafG binding (Fig. 3A). The four point
mutations completely abolished Nrf2zip4p/MafG binding (Fig. 3A).
To prove that what we observed in vitro also occur in vivo, we
performed the ﬂuorescence resonance emission transfer (FRET) assay.
FRET assay has the advantage to discern whether co-localized
molecules bind directly to each other [47]. We used a pair of
ﬂuorophores enhanced cyan ﬂuorescent protein (ECFP) and enhanced
yellow ﬂuorescent protein (EYFP) as FRET donor and acceptor,
respectively. We added an ECFP tag to Nrf2zip (ECFP-Nrf2zip) and
an EYFP tag toMafG (EYFP-MafG).When expressed alone, EYFP tagged
MafG, MafG1p and MafG2p mutants all exhibited a nuclear distribu-
tion pattern (data not shown). Like EGFP-Nrf2zip, ECFP-Nrf2zip
exhibited a cytosolic distribution when expressed alone (data not
shown). These subcellular distribution patterns were consistent with
the epiﬂuorescent microscopic observation of mDsRed-MafG,
mDsRed-MafG2p and EGFP-Nrf2zip, suggesting that the addition of
ﬂuorescent tag did not alter the subcellular distribution of MafG and
Nrf2zip.
At the presence of EYFP-MafG (Fig. 3C), condensed nuclear
accumulation of ECFP-Nrf2zip was observed (Fig. 3D–E). Strong FRET
signals was also detected (Fig. 3B, F), indicating that there was direct
binding between Nrf2zip and MafG proteins. In contrast, in the
absence of MafG, ECFP-Nrf2zip exhibited a cytosolic distribution
(arrowheads, Fig. 3D–E). Single point mutation in MafG (MafG1p)
attenuated the FRET signal (Fig. 3B, J) but failed to abolish Nrf2zip
nuclear retention (Fig. 3H–I). In contrast, double point mutation in
MafG (MafG2p) completely diminished FRET signal (Fig. 3B, N) and
nulliﬁed Nrf2zip nuclear retention (Fig. 3 L–M). In fact, cytosolic
distribution of ECFP-Nrf2zip (Fig. 3 L) and nuclear distribution of
EYFP-MafG2p (Fig. 3K) did not appear to overlap at all (Fig. 3 M). Our
observation that double point mutation (L5AL6A) in the ZIP domain of
MafG disrupted MafG2p/Nrf2zip binding is consistent with the
previous reports that double point mutation (L2PM4P) in the ZIP
domain of MafK can negate MafK/p45 NF-E2 [48] and MafK/Bach2
[46] heterodimerization.
The same effect was also observed when the ZIP domain of Nrf2
was mutated. Whereas single point mutation in the NESzip motif only
attenuated FRET signal, four point mutation could completely
diminish the FRET signal and abolish Nrf2zip4p nuclear localization
(Supplementary Fig. 2).
Therefore mutations disrupting dimerization appeared to con-
comitantly negate Nrf2 nuclear accumulation.
3.4. Dimerization with MafG precluded CRM1/Nrf2zip binding
Previous studies showed that nuclear exporting activity mediated
by NESzip is CRM1-dependent. In an immunoprecipitation study,
CRM1 was found to bind with GFP-Nrf2zip but not GFP-Nrf2zip4pmutant [28]. If Nrf2zip/MafG dimer formation indeed masked the
NESzip motif, NESzip/CRM1 binding should be compromised. To
examine this possibility, we did a GST pull-down assay. In the absence
of MafG protein, GST-Nrf2zip was found to bind with (His)6-CRM1
Fig. 6. Nrf2/MafG dimerization stabilizes Nrf2 proteins. (A) Cell fractionation studies
showed that, at unstressed condition, Nrf2 immunoreactivities observed in nuclear
fraction Nwere enhanced and attenuated when co-expressed withMyc-MafG andMyc-
MafG2p, respectively. (B) After overnight MG132 (10 μM) treatment, similar amount of
Nrf2 immunoreactivities were observed in cells expessing Nrf2 alone or co-expressing
Nrf2 with MafG and MafG2p mutant. Lamin A and GAPDH were used as controls for
endogenous nuclear and cytosolic proteins, respectively. The asterisk indicates weak
Myc-MafG2p immunoreactivity observed in the cytosolic fraction C.
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Nrf2zip/CRM1 binding was attenuated and eventually disappeared
(Fig. 4). Therefore MafG proteins appeared to be able to inhibit
Nrf2zip/CRM1 binding in a dose dependent way.
3.5. MafG-mediated nuclear retention could stabilize Nrf2 proteins
When MafG was co-expressed with Nrf2 in HeLa cells, MafG
exerted a bi-directional transcription regulatory effect. At low
concentrations, MafG ampliﬁed Nrf2 induced ARE-Luciferase activ-
ities in a dose-dependent manner (Fig. 5A). At higher concentra-
tions, the ampliﬁcation effect of MafG was attenuated and even
reversed (Fig. 5A). This observation is consistent with previous
reports [48,49], probably due to the reason that overexpressing
MafG may favor the formation of MafG/MafG homodimer. Since the
MafG/MafG homodimer functions as transcription repressor, they
may compete with MafG/Nrf2 heterodimer and alleviate the up-
regulatory effect exerted by the MafG/Nrf2 heterodimer. Co-expres-
sing dimerization-deﬁcient mutant of MafG, MafG2p, inhibited Nrf2
signaling in a dose-dependent manner (Fig. 5A). In fact, MafG2p
mutant appeared to function as a dominant-negative inhibitor of
Nrf2. In agreement with our reporter gene activity assays, our RT-
PCR assay showed that the transcription of some phase II genes,
including heme oxygenase 1 (HO-1) and NAD(P)H:quinone oxidor-
eductase 1 (NQO1), was signiﬁcantly attenuated when Nrf2 was co-
expressed with MafG2p mutants (Fig. 5B). At protein level, co-
expression of Myc-MafG could remarkably intensify the induction of
HO-1 and NQO1 elicited by Nrf2. In contrast, Myc-MafG2p inhibited
the induction of HO-1 and NQO1 elicited by Nrf2 (Fig. 5C). The
inhibitory effect of Myc-MafG2p was also observed in HEK cells
(Supplementary Fig. 3). It is noteworthy that the immunoreactivities
of Myc-MafG2p were much stronger than that of Myc-MafG (Fig. 5C
and Supplementary Fig. 3). We also observed more intense
expression of MafG2p than MafG with EYFP and mDsRed tags
(data not shown). Since both MafG and MafG2p were constructed in
an identical expressing vector, their in vivo transcription and
translation should be the same. The observed difference of MafG
and MafG2p immunoreactivities may be derived from difference in
degradation. It suggests that the wild type MafG but not the MafG2p
may be controlled by an unraveled negative feedback regulation to
avoid hyperactivity of sMaf/Nrf2 signaling.
When Nrf2 was expressed alone in Hela cells, Nrf2 immunor-
eactivities could be detected in the nuclear fraction. Co-expression
with Myc-MafG increased Nrf2 immunoreactivities in the nucleus. In
contrast, at the presence of Myc-MafG2p, Nrf2 immunoreactivities
were signiﬁcantly attenuated (Fig. 6A). These data suggested that if
Nrf2 protein failed to form a heterodimer with MafG and thus be
retained in cell nucleus, its exit to the cytoplasm might expose it to
proteasomal degradation. In the cytosolic fraction, virtually no Nrf2
immunoreactivities could be detected at ∼110 kD of full length Nrf2.
However, we did observe Nrf2 immunoreactivities at ∼75 kD (Fig. 6A).
It is unknownwhether these ∼75 kD products were degraded form of
Nrf2. For Nrf1, there is a 65 kD isoform functioning as a dominant
negative inhibitor [50]. Further studies are needed to examine this
possibility.
When Hela cells were treated with proteasomal degradation
inhibitor MG132 (10 μM) overnight, similar amount of Nrf2 immunor-
eactivities were detected in nuclear fractions expressing Nrf2 alone
and in nuclear fractions co-expressing Nrf2 with Myc-MafG or Myc-
MafG2p (Fig. 6B). The validity of MG132 effect was also observed in
the increased amount of Myc-MafG2p proteins. Even weak Myc-
MafG2p immunoreactivities could be detected in the cytosolic fraction
(asterisk, Fig. 6B). Intriguingly, we also detected the ∼75 kD bands in
cytosolic fractions of MG132 treated samples (Fig. 6B). In contrast,
only weak ∼110 kD immunoreactivities were detected in the cytosolic
fraction (Fig. 6B).Collectively, these data suggested that MafG-mediated Nrf2
nuclear retention could stabilize Nrf2 protein by preventing its
cytosolic degradation.
4. Discussion
4.1. The ZIP domain is necessary and sufﬁcient for Nrf2/MafG
heterodimerization
In the present study, we ﬁnd that heterodimerization with MafG
can enhance Nrf2 nuclear retention. Nrf2/MafG dimerization can
effectively mask the NESzip motif of Nrf2, as illustrated by the
diminished Nrf2zip/CRM1 binding at the presence of MafG. MafG-
mediated Nrf2 nuclear accumulation appears to be able to stabilize
Nrf2 proteins. For the ﬁrst time, we delineate that the NESzip activity
can be switched off at normal physiological condition.
Our deletion studies show that the ZIP domain is indispensable for
Nrf2/MafG binding (Fig. 2). Previously it is reported that DNA binding
can facilitate dimerization among bZIP proteins [51,52]. Since
dimerization could be formed between Nrf2zip and MafGzip that
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se is competent to mediate dimer formation. Furthermore, the
absence of the basic region also rules out the possibility that the
observed nuclear retention of Nrf2 is actually resulted from the
exposure of a hidden bNLS motif. The speciﬁcity of ZIP–ZIP interaction
is further corroborated by our observation that site-directed muta-
genesis ablating key leucine residues in the ZIP domain can negate
Nrf2/MafG dimerization and Nrf2 nuclear retention (Fig. 3). Collec-
tively, these data show that the ZIP domain per se is necessary and
sufﬁcient for the formation of Nrf2/MafG heterodimer.
4.2. Nrf2/sMafG heterodimerization masks the NESzip motif
Since three composing leucine residues of NESzip are located in the
dimerization interface (Fig. 1A), in the process of Nrf2/MafG hetero-
dimerization, these leucine residues are very likely buried in the
hydrophobic core and consequently become inaccessible to CRM1
binding. Our in vitro competitive binding assay supported this
hypothesis. In a concentration dependent manner, MafG inhibited
Nrf2zip binding to CRM1 (Fig. 4). To further verify whether
dimerization can mask the NESzip motif, selective labeling and
detecting of comprising leucines of the NESzip motif may provide
deﬁnitive evidence. The analytic methods of hydrogen–deuterium
exchange and nuclear magnetic resonance analysis may envision
unequivocally whether these leucine residues are masked or not.
Unfortunately, these expertise are beyond our capability.
The NESzip motif of Nrf2 is highly conserved across-species, with
the only exception of zebra ﬁsh [28]. In contrast, this NESzip motif is
not conserved in Nrf1 and Nrf3 at all [28]. The high cross-species
conservation of Nrf2 NESzip motif implies that the mechanism to
switch-off NESzip motif via heterodimerization may be widely
employed in various Nrf2 proteins and demand further examination.
Oligomerization-regulated NES/NLS activities have been reported
in diverse transcription regulators. A NES motif is characterized in the
tetramerization domain of tumor suppressor factor p53. Tetrameriza-
tion of p53 can occlude this NES and cause p53 nuclear accumulation
[53]. The NES motifs in RXRα [54], Survivin [55], CRKL [56] can be
masked by homodimerization. The NES motif in breast cancer
associated protein BARD1 can be masked by heterodimerization
with BRCA1 [57]. In addition, oligomerization can mask the NLS motif
and lead to cytosolic accumulation of NF-AT4 [58]. Heterodimerizing
with 14-3-3 protein can disable the adjacent NES and NLS motif in
hTERT [59] and cdc25 [60], respectively. Therefore oligomerization-
mediated switch on/off of NES/NLS activities may be extensively
employed as a general regulatory mechanism in cell signaling.
4.3. MafG mediated nuclear retention may potentiate Nrf2 signaling
Nrf2 is a labile protein, with very fast turnover rate [61,62]. Our
present study shows that MafG-mediated Nrf2 nuclear retention can
stabilize Nrf2. Cytoplasmic exclusion of Nrf2 proteins may enable Nrf2
proteins to evade proteasomal degradation (Fig. 5C), as corroborated
by our MG132 study (Fig. 6B). Stabilized Nrf2 may intensify and
prolong antioxidant response (Fig. 5B–C). Previously, small Maf
proteins are only portrayed as obligatory binding partners, escorting
Nrf2 to recognize and bind to ARE/EpRE [6,23]. The present study
however implies that small Maf proteins may not only initiate but also
amplify Nrf2 signaling. Previously, Nioi et al published an elegant
chromosomal immunoprecipitation (ChIP) study. They observed that
the ratio of Nrf2/MafK binding to the NQO1 ARE could increase more
than 10 folds when Hepa-1c1c7 cells were challenged with oxidative
stress [9]. Masking of the NESzip motif, in combine with inactivation
of the NESTA motif [22], may account for effect recruitment of Nrf2 by
sMaf proteins.
Unlike MafG, the heterodimerization-deﬁcient mutant MafG2p
failed to stabilize Nrf2 proteins (Fig. 5C and 6A). We were quitesurprised to observe the dominant negative inhibitory effect exerted
by MafG2p. One prominent observation was that the immunoreactiv-
ities of MafG2p were remarkably higher than that of MafG, both in
Hela cells (Fig. 5C and Fig. 6) and in HEK cells (Supplementary Fig. 3).
The presence of robust MafG2p immunoreactivities suggests that
MafG2p expression may not be regulated like MafG. How high
abundance of MafG2p inhibits Nrf2 signaling in a dominant negative
manner? In addition to the likelihood that MafG2p fails to exclude
Nrf2 from cytosolic degradation, it is also possible that there is
residual binding between MafG2p/sMaf. If the potency of MafG2p/
sMaf dimer formation is only partially compromised, since the sMaf/
sMaf homodimer function as trans-repressor, the accumulated
MafG2p may intensify trans-repression. In future study, we may use
in vitro binding assay to measure the binding afﬁnity among Myc and
V5 tagged wind type andmutant MafG. Furthermore, we can use FRET
assay to examine whether the afﬁnity of MafG/MafG2p binding is
different from MafG/MafG binding.
Since both the NESTA motif and NESzip motif can be switched off, it
naturally raises a question about their relevant importance in the
activation of Nrf2 signaling. Under the homeostatic condition, the
NESTA motif may remain active. So the switch on/off of the NESzip
motif may be more important to affect Nrf2 subcellular distribution
and constitutive induction of phase II genes. If Nrf2 passively enters
into the nucleus, Nrf2 can be arrested by sMaf proteins in the nucleus
via the masking of the NESzip motif. This may partially explain the
observation that the majority cells expressing GFP-Nrf2 exhibited a
whole cell or nuclear distribution pattern [22]. Under the oxidative
condition however, the switch off of the NESTA motif may play the key
role in eliciting Nrf2 nuclear translocation, the masking of NESzip
motif may play a subsequent but indispensable role to reinforce Nrf2
nuclear accumulation and amplify Nrf2 signaling. In other words,
NESTA and NESzip may be implied in different stages of a sequential
Nrf2 activation process.
There is an ARE enhancer in the promoter region of MafG gene
[63]. Therefore, the activation of Nrf2 signaling may elicit a positive
feedback. An oxidative stimulus may not only induce the transcription
of phase II/III genes but also elevate MafG expression. Due to their
nuclear localization, small Maf proteins may be safe from proteasomal
degradation. HigherMafG activities may sensitize the cell, priming the
cell to respond to another oxidative stress more effectively. Further
investigations are necessary to examine whether the antioxidant
response has a context dependent adaptive nature.
The characterization of dimerization-mediated switch off of
NESzip activity may also provide clue to deepen our understanding
whether other mechanism(s) also regulates Nrf2 signaling. Can any
other factor(s) also modify the formation of Nrf2/sMafG dimer?
Recently, it was reported that sumoylation at a consensus SUMO site
(13VKRE16) in MafG can attenuate MafG/p45 NF-E2 transcription
efﬁciency [64]. This sumoylation-mediated active repression is
sensitive to HDAC inhibition [64], implying intricate interplay with
other transcription co-factors. In fact, there is a consensus SUMO site
(515LKDE518) located in the ZIP domain of Nrf2. It requires further
examination whether this site can be sumoylated. It is very tempting
to speculate that sumoylation at this site may inhibit Nrf2/MafG
dimerization. Recently, a tyrosine phosphorylation site (Y560) [65]
and a consensusMAPK site (S561) has been identiﬁed in the vicinity of
Nrf2 ZIP domain. Since phosphorylation may have an impact on an
adjacent SUMO site [66], it remains to be examined whether
phosphorylation at Y560 and/or S561 can have impact on Nrf2/sMaf
dimerization.
In conclusion, we found that the NESzip motif functions as a
conditional NES. The switch on/off of the NESzip motif may have
important functional signiﬁcance. Under unstressed condition, the
constant exposure of the NESzip and NESTA motifs maintains nuclear
exclusion of unbound Nrf2 protein and subjects it to proteasomal
degradation. When Nrf2 signaling is activated by oxidative stress,
1855W. Li et al. / Biochimica et Biophysica Acta 1783 (2008) 1847–1856occlusion of NESzip via dimerizationwith sMaf proteins switches Nrf2
to a stable nuclear accumulation condition. When the oxidative stress
is eased up, the occlusion of NESzip motif may be gradually removed
in parallel to the alleviation of stress response. In combine, these data
delineate that Nrf2 signaling is delicately orchestrated.
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